PMV Pharmaceuticals, Inc. - COMMON STOCK (PMVP)

CUSIP: 69353Y103

Q3 2022 13F Holders as of 30 Sep 2022

Type / Class
Equity / COMMON STOCK
Shares outstanding
53,185,766
Total 13F shares
58,187,852
Share change
-2,938,798
Total reported value
$692,436,457
Put/Call ratio
66%
Price per share
$11.90
Number of holders
116
Value change
-$36,596,424
Number of buys
66
Number of sells
39

Quarterly Holders Quick Answers

What is CUSIP 69353Y103?
CUSIP 69353Y103 identifies PMVP - PMV Pharmaceuticals, Inc. - COMMON STOCK in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PMV Pharmaceuticals, Inc. - COMMON STOCK (PMVP) as of Q3 2022

As of 30 Sep 2022, PMV Pharmaceuticals, Inc. - COMMON STOCK (PMVP) was held by 116 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 58,187,852 shares. The largest 10 holders included ORBIMED ADVISORS LLC, JPMORGAN CHASE & CO, RTW INVESTMENTS, LP, STATE STREET CORP, VANGUARD GROUP INC, BlackRock Inc., BOXER CAPITAL, LLC, Avoro Capital Advisors LLC, Euclidean Capital LLC, and RA CAPITAL MANAGEMENT, L.P.. This page lists 116 institutional shareholders reporting positions in this security for the Q3 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.